Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) beta chain, also known as the common beta chain (βc), is a critical component of the high-affinity receptor complex for GM-CSF, interleukin-3 (IL-3), and interleukin-5 (IL-5). This receptor plays a central role in hematopoiesis and immune regulation by mediating the effects of these cytokines on myeloid cells. The βc subunit does not bind ligand directly but is essential for high-affinity binding to cytokines via heterodimerization with α chains and initiation of intracellular signaling cascades upon ligand binding. Upon activation, cytokine binds to its specific α chain, recruiting the βc subunit to form an active heterodimer. This activates JAK2, leading to phosphorylation events that trigger downstream pathways including JAK/STAT, Ras/MAPK, and PI3K, which regulate cell survival, proliferation, differentiation, and immune responses.
Modulation of myeloid cell function; inhibition of JAK/STAT, MAPK/ERK, or PI3K pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granulocyte-Macrophage Colony-Stimulating Factor Receptor Beta Chain (βc).